Digital Content 
NEWS #PharmaBuzz
03 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tasman-therapeutics-advancing-oral-ketamine-program-to-pivotal-phase-3-studies-302419722.html
11 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/11/3040486/0/en/PharmaTher-Receives-US-FDA-Approval-Goal-Date-for-Ketamine.html
12 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/12/3024966/0/en/PharmaTher-Provides-Update-on-FDA-New-Drug-Application-for-Ketamine.html
22 Jan 2025
// PRESS RELEASE
https://www.investor.jnj.com/news/news-details/2025/SPRAVATO-esketamine-approved-in-the-U.S.-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression/default.aspx
08 Jan 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-8-2025-53657.pdf
07 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hope-therapeutics-inc-and-nrx-pharmaceuticals-inc-nasdaqnrxp-announce-dr-jonathan-javitt-and-dr-david-feifel-to-present-keynote-address-beyond-ketamine-monotherapy-combined-interventional-treatment-of-suicidal-depressi-302344042.html
Share 